Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CITIUS ONCOLOGY, INC. | Director | Stock Option (Right to Buy) | 125K | Dec 12, 2024 | Direct | ||
Citius Pharmaceuticals, Inc. | Director | Stock Option (Right to Purchase Common Stock) | 125K | Nov 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTOR | CITIUS ONCOLOGY, INC. | Dec 12, 2024 | 1 | $0 | 4 | Dec 16, 2024 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 12, 2024 | Director |
CTOR | CITIUS ONCOLOGY, INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Mar 14, 2024 | 1 | $0 | 4 | Mar 18, 2024 | Director |
CTXR | Citius Pharmaceuticals, Inc. | Mar 12, 2024 | 0 | $0 | 3 | Mar 18, 2024 | Director |